These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34977900)

  • 21. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.
    Lejal N; Tarus B; Bouguyon E; Chenavas S; Bertho N; Delmas B; Ruigrok RW; Di Primo C; Slama-Schwok A
    Antimicrob Agents Chemother; 2013 May; 57(5):2231-42. PubMed ID: 23459490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico investigations on the binding efficacy and allosteric mechanism of six different natural product compounds towards PTP1B inhibition through docking and molecular dynamics simulations.
    SarathKumar B; Lakshmi BS
    J Mol Model; 2019 Aug; 25(9):272. PubMed ID: 31451955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA binding.
    Hastie KM; Liu T; Li S; King LB; Ngo N; Zandonatti MA; Woods VL; de la Torre JC; Saphire EO
    Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19365-70. PubMed ID: 22084115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective Covalent Inhibition of "Allosteric Cys121" Distort the Binding of PTP1B Enzyme: A Novel Therapeutic Approach for Cancer Treatment.
    Khan S; Bjij I; Soliman MES
    Cell Biochem Biophys; 2019 Sep; 77(3):203-211. PubMed ID: 31446553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
    Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the role of the conformational flexibility of the active-site lid on the allosteric kinetics of glucosamine-6-phosphate deaminase.
    Bustos-Jaimes I; Sosa-Peinado A; Rudiño-Piñera E; Horjales E; Calcagno ML
    J Mol Biol; 2002 May; 319(1):183-9. PubMed ID: 12051945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: possible contributions to drug resistance and a potential new target site for drugs.
    Perryman AL; Lin JH; McCammon JA
    Protein Sci; 2004 Apr; 13(4):1108-23. PubMed ID: 15044738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How Reactive are Druggable Cysteines in Protein Kinases?
    Awoonor-Williams E; Rowley CN
    J Chem Inf Model; 2018 Sep; 58(9):1935-1946. PubMed ID: 30118220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
    Frembgen-Kesner T; Elcock AH
    J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.
    Goins CM; Dajnowicz S; Thanna S; Sucheck SJ; Parks JM; Ronning DR
    ACS Infect Dis; 2017 May; 3(5):378-387. PubMed ID: 28285521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant.
    Das K; Ding J; Hsiou Y; Clark AD; Moereels H; Koymans L; Andries K; Pauwels R; Janssen PA; Boyer PL; Clark P; Smith RH; Kroeger Smith MB; Michejda CJ; Hughes SH; Arnold E
    J Mol Biol; 1996 Dec; 264(5):1085-100. PubMed ID: 9000632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of RNA Binding on the Structure and Dynamics of the Lassa Virus Nucleoprotein.
    Pattis JG; May ER
    Biophys J; 2016 Mar; 110(6):1246-54. PubMed ID: 27028635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response.
    Reynard S; Russier M; Fizet A; Carnec X; Baize S
    J Virol; 2014 Dec; 88(23):13923-7. PubMed ID: 25253344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations.
    Pan P; Li L; Li Y; Li D; Hou T
    Antiviral Res; 2013 Nov; 100(2):356-64. PubMed ID: 24055835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for the Location of RNA using the Chloride Ion Distribution in Simulations of Virus Capsids.
    Larsson DS; van der Spoel D
    J Chem Theory Comput; 2012 Jul; 8(7):2474-83. PubMed ID: 26588976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The five-to-six-coordination transition of ferric human serum heme-albumin is allosterically-modulated by ibuprofen and warfarin: a combined XAS and MD study.
    Meneghini C; Leboffe L; Bionducci M; Fanali G; Meli M; Colombo G; Fasano M; Ascenzi P; Mobilio S
    PLoS One; 2014; 9(8):e104231. PubMed ID: 25153171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis.
    Oppliger J; Torriani G; Herrador A; Kunz S
    J Virol; 2016 Jul; 90(14):6412-6429. PubMed ID: 27147735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of the Lassa virus nucleoprotein revealed by X-ray crystallography, small-angle X-ray scattering, and electron microscopy.
    Brunotte L; Kerber R; Shang W; Hauer F; Hass M; Gabriel M; Lelke M; Busch C; Stark H; Svergun DI; Betzel C; Perbandt M; Günther S
    J Biol Chem; 2011 Nov; 286(44):38748-38756. PubMed ID: 21917929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever.
    Branco LM; Grove JN; Geske FJ; Boisen ML; Muncy IJ; Magliato SA; Henderson LA; Schoepp RJ; Cashman KA; Hensley LE; Garry RF
    Virol J; 2010 Oct; 7():279. PubMed ID: 20961433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein.
    Shankar S; Whitby LR; Casquilho-Gray HE; York J; Boger DL; Nunberg JH
    J Virol; 2016 Aug; 90(15):6799-807. PubMed ID: 27194767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.